CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability

• Published in: Molecular cancer 2021-08, Vol.20 (1), p.101-101, Article 101
• Main Authors: Zhang, Yu, Jiang, Jiajia, Zhang, Jiayin, Shen, Han, Wang, Maoye, Guo, Zhen, Zang, Xueyan, Shi, Hui, Gao, Jiayan, Cai, Hui, Fang, Xinjian, Qian, Hui, Xu, Wenrong, Zhang, Xu
• Format: Article
• Language: English
• Subjects: Analysis; Animal models; Animals; Biomarker; Cancer; Cell cycle; Cell Line, Tumor; Cell migration; Cell proliferation; CircRNA; Datasets; Development and progression; DIDO1; Disease Models, Animal; DNA-Binding Proteins - chemistry; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Exons; Gastric cancer; Gene expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes; Genes, Tumor Suppressor; Health aspects; Heterografts; Humans; Immunofluorescence; Immunohistochemistry; Immunoprecipitation; Mass spectrometry; Mass spectroscopy; Medical prognosis; Metastases; Metastasis; Mice; Models, Biological; Monosaccharides; Oncology, Experimental; Peroxiredoxin; Peroxiredoxins - chemistry; Peroxiredoxins - metabolism; Poly (ADP-Ribose) Polymerase-1 - metabolism; Poly(ADP-ribose) polymerase; Protein Binding; Protein Stability; Proteins; Proteomics - methods; Ribose; RNA; RNA sequencing; RNA, Circular - genetics; Scientific imaging; Signal Transduction; Software; Stomach cancer; Stomach Neoplasms - genetics; Stomach Neoplasms - metabolism; Stomach Neoplasms - pathology; Sugars; Survival analysis; Target; Therapeutic targets; Transcription; Tumor suppressor genes; Ubiquitination
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-021-01390-y

Circular RNAs (circRNAs) play important roles in cancer development and progression. The purpose of this study is to identify aberrantly expressed circRNAs in gastric cancer (GC), unravel their roles in GC progression, and provide new targets for GC diagnosis and therapy. Bioinformatic analyses were performed to identify the aberrantly expression of hsa_circ_0061137 (termed as circDIDO1) in GC. Gain- and loss-of-function studies were performed to examine the biological roles of circDIDO1 in GC progression. Tagged RNA affinity purification, mass spectrometry, immunofluorescence, co-immunoprecipitation, and Western blot were used to identify circRNA-interacting and circRNA-encoded proteins. RNA sequencing, qRT-PCR, and Western blot were performed to analyze circRNA-regulated downstream target genes and signaling pathways. Mouse tumor models were used to analyze the effects of circDIDO1 on GC growth and metastasis. CircDIDO1 was transcribed from human DIDO1 (death-inducer obliterator 1) gene and formed by back-splicing of exons 2-6 of the linear transcript. circDIDO1 was down-regulated in GC tissues and its low levels were associated with larger tumor size, distal metastasis, and poor prognosis. CircDIDO1 overexpression inhibited while knockdown promoted GC cell proliferation, migration and invasion. CircDIDO1 overexpression suppressed GC growth and metastasis in mouse tumor models. Mechanistically, circDIDO1 encoded a novel 529aa protein that directly interacted with poly ADP-ribose polymerase 1 (PARP1) and inhibited its activity. CircDIDO1 also specifically bound to peroxiredoxin 2 (PRDX2) and promoted RBX1-mediated ubiquitination and degradation of PRDX2, which led to the inactivation of its downstream signaling pathways. CircDIDO1 is a new circRNA that has tumor suppressor function in GC and it may serve as a potential prognostic biomarker and therapeutic target for GC.